Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

Teva
Biotech

Teva saddles up as bidder for bankrupt BioXcel’s CNS assets

BioXcel Therapeutics has filed for bankruptcy and lined up a deal for Teva Pharmaceutical to acquire its assets for $57.5 million upfront.
Nick Paul Taylor Aug 28, 2026 9:17am
Genentech South San Francisco

Genentech doubles down on ADC-resistance via $1B DualityBio pact

Aug 28, 2026 4:30am
Ebola Ebola test

CEPI pushes Egyptian biotech's Ebola vaccine toward clinic

Aug 27, 2026 10:10am
Combine

Osivax bags flu vaccine rights to pursue combination shot vision

Aug 27, 2026 10:00am
Paper family with stethoscope

ProFound forms $35M preeclampsia pact with Gates Foundation

Aug 27, 2026 6:30am
Deal

SK's $795M deal to usher Biohaven’s epilepsy therapy towards FDA

Aug 26, 2026 4:47am